JMP Securities Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price ...
Josh Kerr interview: In Michael Johnson’s new league, I get paid 10 grand even if I lose
Exclusive: British runner, who is preparing a crack at the world indoor mile record, believes new competition could ...
These Philly-area CEOs want to ‘unlock opportunities for more women’
Four Philly-area CEOs discuss how they got to their positions, who helped along the way, and tips for others forging the path ...
JMP Securities Sticks to Its Buy Rating for Protagonist Therapeutics (PTGX)
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...